These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7888688)

  • 1. A reassessment of fasting plasma glucose concentrations in population screening for diabetes mellitus in a community of northern European ancestry: the Wadena City Health Study.
    Clements JP; French LR; Boen JR; Sprafka JM; Hedlund B; Goetz FC
    Acta Diabetol; 1994 Dec; 31(4):187-92. PubMed ID: 7888688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
    Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A
    Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.
    Ko GT; Chan JC; Tsang LW; Cockram CS
    Diabetes Care; 2000 Dec; 23(12):1770-3. PubMed ID: 11128350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study.
    Wu S; Shi Y; Pan Y; Li J; Jia Q; Zhang N; Zhao X; Liu G; Wang Y; Wang Y; Wang C
    BMC Neurol; 2014 Sep; 14():177. PubMed ID: 25209629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
    Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants.
    Prakaschandra R; Naidoo DP
    Ethn Dis; 2018; 28(1):19-24. PubMed ID: 29467562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.
    Sitasuwan T; Lertwattanarak R
    BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA₁c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients.
    Hjellestad ID; Astor MC; Nilsen RM; Søfteland E; Jonung T
    Cardiovasc Diabetol; 2013 May; 12():79. PubMed ID: 23705980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
    Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
    Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA1c predicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose.
    Geberhiwot T; Haddon A; Labib M
    Ann Clin Biochem; 2005 May; 42(Pt 3):193-5. PubMed ID: 15949153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined assessment of glycated albumin and fasting plasma glucose improves the detection of diabetes in Chinese subjects.
    Ma XJ; Pan JM; Bao YQ; Zhou J; Tang JL; Li Q; Xiang KS; Jia WP
    Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):974-9. PubMed ID: 20557319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting.
    Kengne AP; Erasmus RT; Levitt NS; Matsha TE
    Prim Care Diabetes; 2017 Apr; 11(2):119-131. PubMed ID: 28132763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China.
    Bao C; Zhang D; Sun B; Lan L; Cui W; Xu G; Sui C; Wang Y; Zhao Y; Wang J; Li H
    PLoS One; 2015; 10(3):e0119510. PubMed ID: 25785585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.
    Tai ES; Lim SC; Tan BY; Chew SK; Heng D; Tan CE
    Diabet Med; 2000 Nov; 17(11):771-5. PubMed ID: 11131101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.